These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New benzoxazine and benzothiazine derivatives--structure-activity relations in guinea-pig heart and smooth muscle preparations. Studenik C; Lemmens-Gruber R; Heistracher P Pharmazie; 1999 May; 54(5):330-4. PubMed ID: 10368825 [TBL] [Abstract][Full Text] [Related]
3. One pot synthesis of some new substituted hexahydro 2H-1,3-benzoxazine derivatives. Safak C; Simsek R; Altas Y; Erol K; Boydag S Boll Chim Farm; 1996 Sep; 135(8):482-5. PubMed ID: 9035560 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological testing of thiosalicylamides as a novel class of calcium channel blockers. Mehanna AS; Kim JY Bioorg Med Chem; 2005 Jul; 13(13):4323-31. PubMed ID: 15927838 [TBL] [Abstract][Full Text] [Related]
5. Relationship between extra and intracellular sources of calcium and the contractile effect of thiopental in rat aorta. Henkel CC; Asbun J; Ceballos G; del Carmen Castillo M; Castillo EF Can J Physiol Pharmacol; 2001 May; 79(5):407-14. PubMed ID: 11405244 [TBL] [Abstract][Full Text] [Related]
6. L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives. Budriesi R; Cosimelli B; Ioan P; Ugenti MP; Carosati E; Frosini M; Fusi F; Spisani R; Saponara S; Cruciani G; Novellino E; Spinelli D; Chiarini A J Med Chem; 2009 Apr; 52(8):2352-62. PubMed ID: 19323482 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates. Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of some N-benzhydrylpiperazine derivatives as calcium antagonists. Gubert S; Brasó MA; Sacristán A; Ortiz JA Arzneimittelforschung; 1987 Oct; 37(10):1103-7. PubMed ID: 3435581 [TBL] [Abstract][Full Text] [Related]
9. Brazilein-induced contraction of rat arterial smooth muscle involves activation of Ca2+ entry and ROK, ERK pathways. Shen J; Yip S; Wang Z; Wang W; Xing D; Du L Eur J Pharmacol; 2008 Feb; 580(3):366-71. PubMed ID: 18177858 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological characterization of some benzazepinone derivatives. Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P Arzneimittelforschung; 1995 Mar; 45(3):234-9. PubMed ID: 7741775 [TBL] [Abstract][Full Text] [Related]
12. Contribution of the diethyl phosphonate group to a first approach of calcium-inhibiting activity: study of a series of various substituted 2-phenylbenzothiazoles. Mouysset G; de Saqui-Sannes G; Younes S; Bellan J; Payard M; Tisne-Versailles J Farmaco; 1990 Sep; 45(9):945-52. PubMed ID: 2282126 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent. Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of methyl 2-methyl-7,7-dihalo-5-phenyl-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activity. Mojarrad JS; Miri R; Knaus EE Bioorg Med Chem; 2004 Jun; 12(12):3215-20. PubMed ID: 15158789 [TBL] [Abstract][Full Text] [Related]
15. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities. Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents. Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444 [TBL] [Abstract][Full Text] [Related]